1131 related articles for article (PubMed ID: 9443788)
1. Regulation of osteocalcin production and bone resorption by 1,25-dihydroxyvitamin D3 in mouse long bones: interaction with the bone-derived growth factors TGF-beta and IGF-I.
Staal A; Geertsma-Kleinekoort WM; Van Den Bemd GJ; Buurman CJ; Birkenhäger JC; Pols HA; Van Leeuwen JP
J Bone Miner Res; 1998 Jan; 13(1):36-43. PubMed ID: 9443788
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor-beta stimulates bone resorption in neonatal mouse calvariae by a prostaglandin-unrelated but cell proliferation-dependent pathway.
Lerner UH
J Bone Miner Res; 1996 Nov; 11(11):1628-39. PubMed ID: 8915770
[TBL] [Abstract][Full Text] [Related]
3. Differential regulation of insulin-like growth factor-I (IGF-I) and IGF-II release from cultured neonatal mouse calvaria by parathyroid hormone, transforming growth factor-beta, and 1,25-dihydroxyvitamin D3.
Linkhart TA; Keffer MJ
Endocrinology; 1991 Mar; 128(3):1511-8. PubMed ID: 1999170
[TBL] [Abstract][Full Text] [Related]
4. Maturation state determines the response of osteogenic cells to surface roughness and 1,25-dihydroxyvitamin D3.
Lohmann CH; Bonewald LF; Sisk MA; Sylvia VL; Cochran DL; Dean DD; Boyan BD; Schwartz Z
J Bone Miner Res; 2000 Jun; 15(6):1169-80. PubMed ID: 10841186
[TBL] [Abstract][Full Text] [Related]
5. Influence of aluminum on the regulation of PTH- and 1,25(OH)2D3-dependent pathways in the rat osteosarcoma cell line ROS 17/2.8.
Lajeunesse D; Moreau R; Hobbs W; Qui W; Lafond J; Guggino SE
J Bone Miner Res; 1998 Jun; 13(6):962-9. PubMed ID: 9626627
[TBL] [Abstract][Full Text] [Related]
6. 1,25-dihydroxyvitamin D3-mediated transforming growth factor-beta release is impaired in cultured osteoblasts from patients with multiple pituitary hormone deficiencies.
Sterck JG; Klein-Nulend J; Burger EH; Lips P
J Bone Miner Res; 1996 Mar; 11(3):367-76. PubMed ID: 8852947
[TBL] [Abstract][Full Text] [Related]
7. [Effects of various growth factors and hormones on clonal rat pulp cells].
Liang RF
Meikai Daigaku Shigaku Zasshi; 1990; 19(1):1-20. PubMed ID: 2134279
[TBL] [Abstract][Full Text] [Related]
8. Parathyroid hormone sensitizes long bones to the stimulation of bone resorption by 1,25-dihydroxyvitamin D3.
van Leeuwen JP; Birkenhäger JC; Bos MP; van der Bemd GJ; Herrmann-Erlee MP; Pols HA
J Bone Miner Res; 1992 Mar; 7(3):303-9. PubMed ID: 1585831
[TBL] [Abstract][Full Text] [Related]
9. Analysis of osteocalcin expression in transgenic mice reveals a species difference in vitamin D regulation of mouse and human osteocalcin genes.
Clemens TL; Tang H; Maeda S; Kesterson RA; Demayo F; Pike JW; Gundberg CM
J Bone Miner Res; 1997 Oct; 12(10):1570-6. PubMed ID: 9333117
[TBL] [Abstract][Full Text] [Related]
10. Studies on the regulation of insulin-like growth factor binding protein 3 secretion in human osteosarcoma cells in vitro.
Nakao Y; Hilliker S; Baylink DJ; Mohan S
J Bone Miner Res; 1994 Jun; 9(6):865-72. PubMed ID: 7521561
[TBL] [Abstract][Full Text] [Related]
11. Effects of methotrexate on human osteoblasts in vitro: modulation by 1,25-dihydroxyvitamin D3.
Scheven BA; van der Veen MJ; Damen CA; Lafeber FP; Van Rijn HJ; Bijlsma JW; Duursma SA
J Bone Miner Res; 1995 Jun; 10(6):874-80. PubMed ID: 7572311
[TBL] [Abstract][Full Text] [Related]
12. Alendronate interacts with the inhibitory effect of 1,25(OH)2D3 on parathyroid hormone-related protein expression in human osteoblastic cells.
Gómez-García L; Esbrit P; Carreño L; Sabando P; García-Flores M; Martinez ME
J Bone Miner Res; 2003 Jan; 18(1):78-87. PubMed ID: 12510808
[TBL] [Abstract][Full Text] [Related]
13. Effects of transforming growth factor beta 1 on the regulation of osteocalcin synthesis in human MG-63 osteosarcoma cells.
Pirskanen A; Jääskeläinen T; Mäenpää PH
J Bone Miner Res; 1994 Oct; 9(10):1635-42. PubMed ID: 7817811
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor-beta enhances calcitonin-induced cyclic AMP production and the number of calcitonin receptors in long-term cultures of human umbilical cord blood monocytes in the presence of 1,25-dihydroxycholecalciferol.
Mbalaviele G; Orcel P; Bouizar Z; Jullienne A; De Vernejoul MC
J Cell Physiol; 1992 Sep; 152(3):486-93. PubMed ID: 1324244
[TBL] [Abstract][Full Text] [Related]
15. Increase of vascular endothelial growth factor mRNA expression by 1,25-dihydroxyvitamin D3 in human osteoblast-like cells.
Wang DS; Yamazaki K; Nohtomi K; Shizume K; Ohsumi K; Shibuya M; Demura H; Sato K
J Bone Miner Res; 1996 Apr; 11(4):472-9. PubMed ID: 8992878
[TBL] [Abstract][Full Text] [Related]
16. Parathyroid hormone increases the concentration of insulin-like growth factor-I and transforming growth factor beta 1 in rat bone.
Pfeilschifter J; Laukhuf F; Müller-Beckmann B; Blum WF; Pfister T; Ziegler R
J Clin Invest; 1995 Aug; 96(2):767-74. PubMed ID: 7635970
[TBL] [Abstract][Full Text] [Related]
17. Regulation of collagen type I and biglycan mRNA levels by hormones and growth factors in normal and immortalized osteoblastic cell lines.
Thiébaud D; Guenther HL; Porret A; Burckhardt P; Fleisch H; Hofstetter W
J Bone Miner Res; 1994 Sep; 9(9):1347-54. PubMed ID: 7817818
[TBL] [Abstract][Full Text] [Related]
18. Menatetrenone inhibits bone resorption partly through inhibition of PGE2 synthesis in vitro.
Hara K; Akiyama Y; Tajima T; Shiraki M
J Bone Miner Res; 1993 May; 8(5):535-42. PubMed ID: 8511981
[TBL] [Abstract][Full Text] [Related]
19. Inducible production of nitric oxide in osteoblast-like cells and in fetal mouse bone explants is associated with suppression of osteoclastic bone resorption.
Löwik CW; Nibbering PH; van de Ruit M; Papapoulos SE
J Clin Invest; 1994 Apr; 93(4):1465-72. PubMed ID: 8163651
[TBL] [Abstract][Full Text] [Related]
20. 24R,25-dihydroxyvitamin D3 increases cyclic GMP contents, leading to an enhancement of osteocalcin synthesis by 1,25-dihydroxyvitamin D3 in cultured human osteoblastic cells.
Yamamoto T; Ozono K; Shima M; Yamaoka K; Okada S
Exp Cell Res; 1998 Oct; 244(1):71-6. PubMed ID: 9770350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
